Low-grade endometrial stromal sarcoma: Contribution of hormone therapy and etoposide;Sarcome du chorion cytogène de bas grade: Mise au point sur l'intérêt de l'hormonothérapie et de l'étoposide à partir de 4 cas

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 34, Issue 1, 2005, Pages 41-46

  Paillocher, N ^a   Lortholary, A ^b   Abadie Lacourtoisie, S ^c   Morand, C ^c   Verriele, V ^c   Catala, L ^a   Descamps, P ^a  

^a HÔTEL DIEU   (France)

^b Centre Catherine de Sienne   (France)

^c CENTRE PAUL PAPIN   (France)

Author keywords

Endometrial stromal sarcoma; Etoposide; Hormone therapy; Low grade

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; ETOPOSIDE; MEDROXYPROGESTERONE ACETATE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; ALOPECIA; ANEMIA; ARTICLE; ASTHENIA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER REGRESSION; CASE REPORT; ENDOMETRIUM CANCER; ENDOMETRIUM SARCOMA; FEMALE; HUMAN; REMISSION; SIDE EFFECT; TREATMENT OUTCOME;

EID: 13244268558     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0368-2315(05)82669-9     Document Type: Article

References (23)

1. Melilli GA, Di Vagno G, Greco P, Vimercati A, Loizzi V, Putignano G, et al. Endometrial stromal sarcoma: a clinicopathologic study. Eur J Gynaecol Oncol 1999; 20: 33-4.
2. Pautier P, Genestie C, Rey A, Morice P, Roche B, Lhommé C et al. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer 2000; 88: 1425-31.
3. Morris HJ, Taylor HB. Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer 1966; 19: 755-66.
4. Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Urgesi A, et al. Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol 1996; 63: 247-53.
5. Bodner K, Bodner-Adler B, Obermair A, Windbichler G, Petru E, Mayerhofer S, et al. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol 2001; 81: 160-5.
6. Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Cosio S et al. The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task force multivariate analysis of 249 cases. Eur J Gynaecol Oncol 2002; 23: 295-9.
7. Huang KT, Chen CA, Tseng GC, Chen TM, Cheng WF, Hsieh CY. Endometrial stromal sarcoma of twenty cases. Acta Obstet Gynecol Scand 1996; 75: 551-5.
8. Tabata T, Takeshima N, Hirai Y, Hasumi K. Low-grade endometrial stromal sarcoma with cardiovascular involvement-a report of three cases. Gynecol Oncol 1999; 75: 495-8.
9. Kondi-Paphitis A, Smymiotis B, Liapis A, Kontoyanni A, Deligeorgi H. Stromal sarcoma arising on endometriosis. A clinicopathological and immunohistochemical study of 4 cases. Eur J Gynaecol Oncol 1998; 19: 588-90.
10. Reich O, Pickel H, Regauer S. Cytologic diagnosis of low grade endometrial stromal sarcoma by staining for estrogen and progesterone receptors. Acta Cytol 2002; 46: 790-2.
11. Agoff SN, Grieco VS, Garcia R, Gown AM. Immunohistochemical distinction of endometrial stromal sarcoma and cellular leiomyoma. Appl Immunohistochem Mol Morphol 2001; 9: 164-9.
12. Reich O, Regauer S, Urdl W. Heterogeneous oestrogen - and progesterone-receptor expression in low-grade endometrial stromal sarcomas-implications for therapy. Eur J Cancer 2000; 36: 108.
13. Chu MC, Mor G, Lim C, Zheng W, Parkash V, Schwarte PE. Low grade endometrial stromal sarcoma: hormonal aspects. Gynecol Oncol 2003; 90: 170-6.
14. Piver MS, Rutledge FN, Copeland L, Webster K, Blumenson L, Suh O. Uterine endolymphatic stromal myosis: a collaborative study. Obstet Gynecol 1984; 64: 173-8.
15. Ishiko O, Wakasa K, Honda K, Nakajima S, Ogita S. Excellent results of postoperative radiotherapy for endometrial stromal sarcoma of low-grade malignancy. Gynecol Obstet Invest 2000; 49: 214-6.
16. Lin YC, Kudelka AP, Tresukosol D, Malpica A, Carrasco CH, Lawrence DD, et al. Prolonged stabilization of progressive endometrial stromal sarcoma with prolonged oral etoposide therapy. Gynecol Oncol 1995; 58: 262-5.
17. Tsukamoto N, Kamura T, Matsukuma K, Imachi M, Uchino H, Saito T, et al. Endolymphatic stromal myosis: a case with positive estrogen and progesterone receptors and good response to progestins. Gynecol Oncol 1985; 20: 120-8.
18. Gloor E, Schnyder P, Cikes M, Hofstetter J, Cordey R, Burnier F, et al. Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy. Cancer 1982; 50: 1888-93.
19. Katz L, Merino MJ, Sakamoto H, Schwartz PE. Endometrial stromal sarcoma: a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors. Gynecol Oncol 1987; 26: 87-97.
20. Maluf FC, Sabbatini P, Schwartz L, Xia J, Aghajanian C. Endometrial stromal sarcoma: objective response to letrozole. Gynecol Oncol 2001; 82: 384-8.
21. Spano JP, Soria JC, Kambouchner M, Piperno-Neuman S, Morin F, Morere JF et al. Long term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma. Med Oncol 2003; 20: 87-93.
22. Berchuck A, Rubin SC, Hoskins WJ, Saigo PE, Pierce VK, Lewis JL J. Treatment of endometrial stromal tumors. Gynecol Oncol 1990; 36: 60-5.
23. Soumarova R, Horova H, Seneklova Z, Ruzickova J, Horova I, Budikova M et al. Treatment of uterine sarcoma. A survey of 49 patients. Arch Gynecol Obstet 2002; 266: 92-5.